The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

AbbVie's Allergan and Evolus have been locked in a yearslong trade secrets fight involving the two drugmakers' South Korean partners and blockbuster Botox. Despite some early promise for Evolus, a U.S ...

With a $63 billion merger nearing approval, AbbVie is counting on Allergan and its cash-cow Botox to boost sales—and that superstar could be a long-term winner. But not every drug in Allergan's stable ...

Shares of Irvine-based Allergan Inc. jumped Monday as Wall Street got its first crack at the stock after word Friday that the company’s flagship Botox drug was approved as a treatment for migraine ...

SANTA ANA, Calif. (CN) - Finding that a German company stole trade secrets, a federal judge blocked Merz Pharmaceuticals for 10 months from selling a botulinum-based product that competes with ...

CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...

For Allergan Inc., a subtle offense has proved the best defense in the court of public opinion over Botox. Observers give the Irvine drug maker good marks for its strategy in support of Allergan’s ...

U.S. District Judge Eli Richardson in Nashville, Tennessee, ruled, opens new tab that Allergan plausibly alleged that Revance had acquired and used some of its rival’s trade secrets amid a series of ...

We’re adding branded drug giant Allergan (AGN), which is based in Ireland, to our model portfolio, says biotech and healthcare sector expert Bret Jensen, editor of Investors Alley’s Biotech Gems.

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A federal jury July 18 said Revance Therapeutics' skin ...